- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Chronic Spontaneous Urticaria
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Article
Dr. Zoe Diana Draelos joins Histogen’s scientific advisory board
San Diego - Histogen has announced that Zoe Diana Draelos, M.D., will be joining the company’s scientific advisory board, PR Newswire reports.
San Diego
- Histogen has announced that Zoe Diana Draelos, M.D., will be joining the company’s scientific advisory board, PR Newswire reports.
Dr. Draelos, president of Dermatology Consulting Services, will aid the company in clinical evaluations and product launches in the cosmetic arena.
Histogen is a regenerative medicine company developing products through newborn fibroblasts. Histogen Aesthetics focuses on the development of skin and haircare products for the dermatology, plastic surgery and cosmetics industries.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
